dibutyryl cyclic-3',5'-cytidine monophosphate and adenosine diphosphate

dibutyryl cyclic-3',5'-cytidine monophosphate has been researched along with adenosine diphosphate in 2 studies

Compound Research Comparison

Studies (dibutyryl cyclic-3',5'-cytidine monophosphate)	Trials (dibutyryl cyclic-3',5'-cytidine monophosphate)	Recent Studies (post-2010) (dibutyryl cyclic-3',5'-cytidine monophosphate)	Studies (adenosine diphosphate)	Trials (adenosine diphosphate)	Recent Studies (post-2010) (adenosine diphosphate)
72	0	18	23,989	498	3,114

Protein Interaction Comparison

Protein	Taxonomy	adenosine diphosphate (IC50)
Chain A, Kinesin-like protein KIF11	Homo sapiens (human)	0.45
Heat shock 70 kDa protein 1A	Homo sapiens (human)	0.5
Sensor protein kinase WalK	Staphylococcus aureus	7.189

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cattaneo, M; Lecchi, A	1
Balaban, RS; Covian, R; French, S; Kusnetz, H	1

Other Studies

2 other study(ies) available for dibutyryl cyclic-3',5'-cytidine monophosphate and adenosine diphosphate

Article	Year
Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin. Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:3 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenylyl Cyclases; Blood Platelets; Cyclic AMP; Cyclic CMP; Deoxyadenine Nucleotides; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Serotonin; Thrombin	2007
Stimulation of oxidative phosphorylation by calcium in cardiac mitochondria is not influenced by cAMP and PKA activity. Biochimica et biophysica acta, 2014, Volume: 1837, Issue:12 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine Diphosphate; Animals; Calcium; Catalytic Domain; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic CMP; Cytochrome b Group; Electron Transport; Electron Transport Complex I; Electron Transport Complex III; Electron Transport Complex IV; Isoquinolines; Mitochondria, Heart; NAD; Oxidative Phosphorylation; Oxygen Consumption; Protein Kinase Inhibitors; Spectrometry, Fluorescence; Spectrophotometry; Sulfonamides; Swine	2014

Article

Year

Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin.

Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:3

Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenylyl Cyclases; Blood Platelets; Cyclic AMP; Cyclic CMP; Deoxyadenine Nucleotides; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Serotonin; Thrombin

2007

Stimulation of oxidative phosphorylation by calcium in cardiac mitochondria is not influenced by cAMP and PKA activity.

Biochimica et biophysica acta, 2014, Volume: 1837, Issue:12

Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine Diphosphate; Animals; Calcium; Catalytic Domain; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic CMP; Cytochrome b Group; Electron Transport; Electron Transport Complex I; Electron Transport Complex III; Electron Transport Complex IV; Isoquinolines; Mitochondria, Heart; NAD; Oxidative Phosphorylation; Oxygen Consumption; Protein Kinase Inhibitors; Spectrometry, Fluorescence; Spectrophotometry; Sulfonamides; Swine

2014